Trivago's Tribulations Not Likely Negative For Priceline, Expedia
Shares of Trivago NV - ADR (NASDAQ: TRVG) were hard hit Wednesday after the European-based hotel search company issued a guidance warning. The company cautioned investors that its revenue growth rate for 2017 will be 40 percent year over year, which marks a deceleration from the prior guidance of 50-percent growth.
The main question from this guidance warning is what impact will Trivago's outlook have on the rest of the online travel agency space? Analysts at Bank of America answered this question and believe that Trivago's woes are company specific and not indicative of broader weakness across the entire sector.
Bank of America's Nat Schindler downgraded Trivago's stock rating from Buy to Neutral with a price target lowered from $22 to $14 as the company's guidance warning indicated it is less competitive in performance marketing channels that have a negative impact on traffic.
Trivago's warning can also be attributed to the "unwinding of the relevance assessment" which previously served as a reason for advertisers to pay a premium to the company, the analyst noted. But at the same time advertisers were making improvements to their own sites, which imply that premium bids were reduced and had a larger than expected impact on Trivago's traffic monetization and growth.
Also important to note, Trivago didn't cite any travel related demand issues in its guidance warning, Schindler also stated. As such, there is no change to the analyst's prior positive stance on Trivago's peers including Priceline Group Inc (NASDAQ: PCLN) and Expedia Inc (NASDAQ: EXPE).
At last check, shares of Trivago were down 4.68 percent at $11.90.
Related Links:
5 Biggest Price Target Changes For Thursday
Benzinga's Top Upgrades, Downgrades For September 7, 2017
Latest Ratings for EXPE
Date | Firm | Action | From | To |
---|---|---|---|---|
Apr 2021 | Wolfe Research | Initiates Coverage On | Peer Perform | |
Mar 2021 | Gordon Haskett | Initiates Coverage On | Buy | |
Mar 2021 | Morgan Stanley | Maintains | Equal-Weight |
View More Analyst Ratings for EXPE
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Analyst Color News Guidance Travel Analyst Ratings Movers Tech General Best of Benzinga